AdCheck – helping you comply with confidence

From 1 July, those who create and/or place therapeutic goods advertising to consumers will have to manage their compliance obligations without the safety net provided by mandatory pre-approvals.

The TGAC is a complex, living document, with hundreds of pages of TGA guidance to assist advertisers with its more nuanced elements.

An estimated 60-70% of ads submitted for mandatory pre-approvals to CHP Australia’s Advertising Services Office required some form of compliance amendment.

Noncompliance risks not only TGA enforcement action, including fines up to $10 million and criminal prosecution, but also:

  • Brand and reputational damage.
  • Jeopardising creative and financial investments made to develop a brand.
  • Opportunity loss and creative costs of relaunching ad campaigns.
  • Administrative and legal costs managing complaints and noncompliance issues.

Advertisers, in adapting to this new compliance environment and the end of the pre-approval’s safety net, should reassess their compliance obligations, capabilities and liabilities.

Using an independent compliance service with dedicated TGAC experts, like AdCheck, can help minimise the risk of noncompliance.

AdCheck, provided by CHP Australia, offers independent, expert compliance checks and advice on all forms of direct to consumer therapeutic goods advertising.

AdChecks are performed by the same CHP compliance experts who previously provided mandatory pre-approvals.

How AdCheck works


AdCheck’s comprehensive services are available 1 July to any company that creates and/or places therapeutic goods ads, not just CHP Australia members, and include:

  • Timely and dependable compliance checks regardless of the ad’s consumer audience or communication medium.
  • Expert guidance and advice to address compliance issues.
  • Early stage concept consultations and advice.
  • Coaching and compliance training.
  • Support and advice managing complaints.
  • Unique AdCheck verification number.

Don’t run the risk – submit for AdCheck.

For more information about the AdCheck service, visit


Must Read

Laws surrounding vaping and nicotine e-liquids are inciting much controversy in the industry.

Vaping nicotine rescheduled

Nicotine for use in e-cigarettes will soon only be available to Australians via a prescription. This decision is an interim one made by the Therapeutic...